clopidogrel has been researched along with Thrombocytopathy in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, PC; Brighton, T; Chan, MV; Chen, Q; Chen, V; Connor, D; Crescente, M; Donikian, D; Hsu, H; Joseph, J; Kondo, M; Morel-Kopp, MC; Rabbolini, DJ; Stevenson, WS; Ward, C; Warner, TD | 1 |
| García-Chavez, J; Hernández-Reyes, J; Rosales-Padrón, J; Ruiz-Arguelles, A; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Vargas-Espinosa, J; Velázquez-Sánchez-de-Cima, S; Zamora-Ortiz, G | 1 |
| Bouatou, Y; Gabrielli, A; Saudan, P | 1 |
| Ahmad, S; Barnes, SL; Bartels, A; Coberly, J; Coughenour, J; Hammer, RD; Hughes, N; Kessel, J; Litofsky, NS; Litt, J; Nelson, C; Quick, J; Sarpong, Y | 1 |
| Hacquard, M; Lacour, JC; Lecompte, T; Richard, S; Vespignani, H | 1 |
| Alberts, MJ; Batjer, HH; Bendok, BR; Bernstein, RA; Bleck, TP; Garg, RK; Naidech, AM | 1 |
| Aradi, D; Horváth, IG; Komócsi, A; Lenkey, Z; Vorobcsuk, A | 1 |
| Douma, S; Ferro, A; Gkaliagkousi, E; Passacquale, G; Zamboulis, C | 1 |
| Itzkovsky, K; Kogan, A; Leikin, G; Preisman, S; Raanani, E | 1 |
| Lindhoff-Last, E; Mani, H; Wolf, Z | 1 |
| Cattaneo, M | 1 |
| Alexopoulos, D; Plakomyti, TE; Xanthopoulou, I | 1 |
| Alberio, L; Friess, D; Lämmle, B | 1 |
| Patscheke, H | 1 |
| Bucha, E; Nowak, G; Schumann, A | 1 |
| Hassan, AA; Kroll, MH | 1 |
4 review(s) available for clopidogrel and Thrombocytopathy
| Article | Year |
|---|---|
[Use of antiplatelet agents in patients with chronic kidney disease: what is the evidence?].
Topics: Adenosine; Blood Platelet Disorders; Clopidogrel; Evidence-Based Practice; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Renal Insufficiency, Chronic; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine | 2014 |
[Significance of platelet function tests].
Topics: Adenosine Diphosphate; Arachidonic Acid; Aspirin; Blood Platelet Disorders; Clopidogrel; Collagen; Hemorrhagic Disorders; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Prognosis; Ristocetin; Ticlopidine | 2010 |
The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.
Topics: Adenosine; Adenosine Diphosphate; Animals; Blood Platelet Disorders; Blood Platelets; Clopidogrel; Female; Hemorrhage; Humans; Male; Mice; Mutation; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Signal Transduction; Thiophenes; Ticagrelor; Ticlopidine | 2011 |
[Platelet aggregation disorders].
Topics: Blood Platelet Disorders; Clopidogrel; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thrombin; Ticlopidine | 2003 |
2 trial(s) available for clopidogrel and Thrombocytopathy
| Article | Year |
|---|---|
Primary thrombophilia in México X: a prospective study of the treatment of the sticky platelet syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelet Disorders; Child; Clopidogrel; Female; Humans; Male; Mexico; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Syndrome; Thrombophilia; Thrombosis; Ticlopidine; Young Adult | 2015 |
Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery.
Topics: Aged; Aspirin; Blood Platelet Disorders; Clopidogrel; Coronary Artery Bypass; Drug Administration Schedule; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Prognosis; Thrombelastography; Ticlopidine | 2010 |
10 other study(ies) available for clopidogrel and Thrombocytopathy
| Article | Year |
|---|---|
A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelet Disorders; Clopidogrel; Humans; Pilot Projects; Platelet Aggregation; Platelet Function Tests | 2022 |
Failure of the Platelet Function Assay (PFA)-100 to detect antiplatelet agents.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelet Disorders; Brain Injuries; Clopidogrel; False Negative Reactions; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Retrospective Studies; Stroke; Ticlopidine | 2015 |
Levetiracetam-induced platelet dysfunction.
Topics: Aged; Anticonvulsants; Blood Platelet Disorders; Clopidogrel; Humans; Levetiracetam; Magnetic Resonance Imaging; Male; Piracetam; Platelet Aggregation; Platelet Aggregation Inhibitors; Seizures; Ticlopidine | 2009 |
Reduced platelet activity is associated with more intraventricular hemorrhage.
Topics: Adult; Aged; Aspirin; Blood Platelet Disorders; Blood Platelets; Cerebral Hemorrhage; Clopidogrel; Cohort Studies; Comorbidity; Disease Progression; Female; Humans; Lateral Ventricles; Male; Middle Aged; Outcome Assessment, Health Care; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine | 2009 |
Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity.
Topics: Aged; Blood Platelet Disorders; Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome | 2010 |
Platelet activation in essential hypertension: implications for antiplatelet treatment.
Topics: Antihypertensive Agents; Blood Platelet Disorders; Blood Platelets; Clopidogrel; Humans; Hypertension; Platelet Activation; Platelet Aggregation Inhibitors; Thrombosis; Ticlopidine | 2010 |
Variability and treatment of high on-prasugrel platelet reactivity in patients with initial high on-clopidogrel platelet reactivity.
Topics: Blood Platelet Disorders; Clopidogrel; Female; Humans; Male; Middle Aged; Piperazines; Platelet Activation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticlopidine | 2012 |
Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
Topics: Aged; Aspirin; Blood Platelet Disorders; Clopidogrel; Hemorrhage; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polycythemia Vera; Thrombosis; Ticlopidine | 2003 |
Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?
Topics: Abciximab; Aged; Antibodies, Monoclonal; Blood Platelet Disorders; Blood Platelets; Cell Separation; Clopidogrel; Dose-Response Relationship, Drug; Eptifibatide; Female; Fibrinogen; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Peptides; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Polymers; Pyridines; Ticlopidine; Tirofiban; Tyrosine | 2005 |
Acquired disorders of platelet function.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bleeding Time; Blood Platelet Disorders; Blood Platelets; Clopidogrel; Hemostatics; Humans; Medical History Taking; Platelet Aggregation Inhibitors; Platelet Transfusion; Ticlopidine | 2005 |